The FDA approval of Amgen, Inc’s (NASDAQ: AMGN) biosimilar version of Johnson & Johnson's (NYSE: JNJ) psoriasis treatment, Stelara, for multiple inflammatory diseases sent
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) spiked higher on Wednesday after the company reported upbeat third-quarter earnings earlier this week.